#daewoongpharmaceutical — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #daewoongpharmaceutical, aggregated by home.social.
-
Daewoong Pharmaceutical has partnered with Sweden's Salipro Biotech to accelerate next-generation drug development using Salipro's membrane protein stabilization platform.
#YonhapInfomax #DaewoongPharmaceutical #SaliproBiotech #NewDrugDevelopment #MembraneProtein #SaliproPlatform #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=66965 -
Daewoong Pharmaceutical reports Q1 operating profit of 42 billion won, up 34% year-on-year, meeting market expectations amid sales growth and improved profitability
#YonhapInfomax #DaewoongPharmaceutical #Q1Earnings #OperatingProfit #MarketConsensus #StockPerformance #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=60739 -
Daewoong Pharmaceutical reports strong Q1 performance with 34% year-on-year increase in operating profit, aligning with market expectations
#YonhapInfomax #DaewoongPharmaceutical #Q1Earnings #OperatingProfit #YearOnYearGrowth #MarketExpectations #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=60734 -
Hanwha Systems, Daewoong Pharmaceutical, and Hanjin KAL exceed corporate bond demand targets, with Hanwha Systems securing over 1 trillion won in orders, signaling strong investor confidence despite varying credit ratings.
#YonhapInfomax #HanwhaSystems #CorporateBonds #DemandForecast #DaewoongPharmaceutical #HanjinKAL #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=59598 -
Daewoong Pharmaceutical seeks to raise up to 180 billion won through corporate bonds, showing confidence in performance amid facility investments and R&D expansion
#YonhapInfomax #DaewoongPharmaceutical #CorporateBonds #FacilityInvestment #RDExpenses #PerformanceOutlook #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=59313 -
Daewoong Pharmaceutical reports record performance driven by new drugs, but faces challenges with increased debt and ongoing Nabota lawsuit, highlighting both growth and uncertainties in the pharmaceutical sector.
#YonhapInfomax #DaewoongPharmaceutical #RecordPerformance #NewDrugs #DebtIncrease #NabotaLawsuit #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=58719 -
Daewoong Pharmaceutical enters India's anti-ulcer market with Fexuclue launch, aiming for global expansion and trillion-won sales milestone by 2030
#YonhapInfomax #DaewoongPharmaceutical #Fexuclue #IndiaMarket #AntiUlcerDrug #GlobalExpansion #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=57508